EMEA-001877-PIP01-15-M02

Key facts

Invented name
Ajovy
Active substance
fremanezumab
Therapeutic area
Neurology
Decision number
P/0411/2019
PIP number
EMEA-001877-PIP01-15-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Prevention of migraine headaches
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Teva GmbH

Tel. +41 552201546
E-mail: info-era-clinical@teva.de

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
2 ratings